StockData
Regeneron Pharmaceuticals, Inc. logo

Regeneron Pharmaceuticals, Inc.

REGNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 16/3011% above fair value
$920.69−2.65 (-0.29%)

Close on Nov 20, 2026Market cap $95.24BP/E 20.3Yield –

Regeneron Pharmaceuticals Evkeeza by Quarter

Evkeeza — U.S. Net Product Sales Recorded by Regeneron ($M) ($M)

Regeneron Pharmaceuticals Evkeeza: $55.5M in Q3 2026, up 29.7% from a year earlier. That is the highest of the 27 quarters on record here.

Latest, Q3 2026
55.5
Period ended Sep 30, 2026
Change on a year earlier
+29.7%
42.8 in Q3 2025
History
27 quarters
Since Q1 2020
Sources
22
Documents cited below

Where the Q3 2026 figure comes from

Source: Form 10-Q (filed 2026-10-30) ↗

Reported in Form 10-Q / 10-K Note — Net Product Sales (XBRL).

quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedEvkeeza — U.S. Net Product Sales Recorded by Regeneron ($M) ($M)Year on yearSource
Q3 2026Sep 30, 202655.5+29.7%Form 10-Q (filed 2026-10-30) ↗
Q2 2026Jun 30, 202653.3+29.4%Form 10-Q (filed 2026-07-30) ↗
Q1 2026Mar 31, 202645.7+47.9%Form 10-Q (filed 2026-04-29) ↗
Q4 2025Dec 31, 202547.3+24.1%Form 10-K (filed 2026-02-04) ↗
Q3 2025Sep 30, 202542.8+32.1%Form 10-Q (filed 2026-10-30) ↗
Q2 2025Jun 30, 202541.2+35.5%Form 10-Q (filed 2026-07-30) ↗
Q1 2025Mar 31, 202530.9+24.6%Form 10-Q (filed 2026-04-29) ↗
Q4 2024Dec 31, 202438.1+58.8%Form 10-K (filed 2026-02-04) ↗
Q3 2024Sep 30, 202432.4+69.6%Form 10-Q (filed 2025-10-28) ↗
Q2 2024Jun 30, 202430.4+57.5%Form 10-Q (filed 2025-08-01) ↗
Q1 2024Mar 31, 202424.8+66.4%Form 10-Q (filed 2025-04-29) ↗
Q4 2023Dec 31, 202324+55.8%Form 10-K (filed 2026-02-04) ↗
Q3 2023Sep 30, 202319.1+40.4%Form 10-Q (filed 2024-10-31) ↗
Q2 2023Jun 30, 202319.3+73.9%Form 10-Q (filed 2024-08-01) ↗
Q1 2023Mar 31, 202314.9+75.3%Form 10-Q (filed 2024-05-02) ↗
Q4 2022Dec 31, 202215.4+65.6%Form 10-K (filed 2025-02-05) ↗

Breakdown

What makes up evkeeza

Cite this data

StockData. (2026). Regeneron Pharmaceuticals Evkeeza ($M), quarterly Q1 2020–Q3 2026 [Data set]. Compiled from Regeneron Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/regn/kpis/rev-evkeeza-us

See every metric in the Regeneron Pharmaceuticals KPI table. Data updated Nov 4, 2026.

See a number that looks wrong?